Articles tagged "Kidney"

2021 American Transplant Congress
Associations of Lack of Insurance and Other Sociodemographic Traits with Deficiencies in Follow-Up After Living Kidney Donation
K. Lentine¹, R. Hays², N. Lam³, A. Tietjen⁴, A. Muiru⁵, H. Xiao¹, A. Garg⁶, C. Thomas⁷, G. McNatt⁷, R. Howey⁸, U. Lebron-Banks⁹, M. Cooper¹⁰, M. Conboy¹¹, B. Kasiske¹¹
¹Saint Louis Univ, Saint Louis, MO, ²Univ of Wisconsin, Madison, WI, ³Univ of Calgary, Calgary, AB, Canada, ⁴St. Barnabas, Livingston, NJ, ⁵Univ of California, San Francisco, San Francisco, CA, ⁶Western Univ, London, ON, Canada, ⁷Univ of Iowa, Iowa City, IA, ⁸Toyon Associates, Concord, CA, ⁹New York Presb Hosp, New York, NY, ¹⁰Medstar-Georgetown, Washington, DC, ¹¹SRTR, Minneapolis, MN
*Purpose: Follow-up after living kidney donation in the United States has improved with recent policy mandates. We hypothesized that lack of insurance at donation may…
2021 American Transplant Congress
A Reliable Non Invasive Alternative to Surveillance Renal Allograft Biopsy
R. Jain, S. Thaduri, V. Kumar, C. Kew, B. Julian, G. Towns, S. Ong, F. Ahmed, S. Mehta, G. Agarwal
Transplant Nephrology, University of Alabama Birmingham, Birmingham, AL
*Purpose:Surveillance Renal Allograft Biopsy (SAVB) is the standard of care to identify subclinical immunological injury(SCI). However fewer than 25% of transplant centers in the US…
2021 American Transplant Congress
Exploring the Correlation with Donor Hepatitis C Viral Load and Viral Kinetics in Naïve Kidney Transplantation Recipients
A. Brooks¹, A. Rechnitzer¹, R. Teo¹, D. Y. Goldstein², M. Narlieva², J. P. Rocca¹, M. Ajaimy¹, L. Liriano-Ward¹, Y. Azzi¹, C. Pynadath¹, P. Loarte-Campos¹, E. Akalin¹, M. E. Le¹, H. Yaffe¹, S. Greenstein¹, J. Torabi¹, M. M. Kinkhabwala¹, J. A. Graham¹
¹Montefiore-Einstein Center for Transplantation, Montefiore Medical Center, Bronx, NY, ²Pathology, Montefiore Medical Center, Bronx, NY
*Purpose: The transplantation of Hepatitis C viremic (HCV) kidneys into uninfected recipients was made possible by effective direct acting anti-viral (DAA) therapy. This study aims…
2021 American Transplant Congress
Immunosuppression Regimen and Risk of Posttransplant Diabetes Among Older Kidney Transplant Recipients
K. Lentine¹, J. Ahn², M. McAdams Demarco², H. Xiao¹, S. Bunnapradist³, D. Segev², D. Axelrod¹, S. Bae², V. Dharnidharka⁴, Y. Caliskan¹, S. Chang⁴, G. Hess⁵, J. Snyder⁶, M. Schnitzler¹
¹Saint Louis Univ, Saint Louis, MO, ²Johns Hopkins, Baltimore, MD, ³Univ of California, Los Angeles, Los Angeles, CA, ⁴Washington Univ, Saint Louis, MO, ⁵Drexel Univ, Philadelphia, PA, ⁶SRTR, Minneapolis, MN
*Purpose: Posttransplant diabetes mellitus (PTDM) is a common complication after kidney transplantation (KTx), which may be exacerbated by immunosuppressive therapy (ISx). Older adults tend to…
2021 American Transplant Congress
Evaluation of the Impact of Delayed Graft Function (dgf) on Kidney Allograft Outcomes
J. Leeds, B. Rawashdeh, M. Sestito, B. Sharma, J. Kamal, A. Kumar, A. AgarwalAA4VB, A. Doyle, S. Rao
University of Virginia, Charlottesville, VA
*Purpose: DGF is an important post-transplant complication that has early and long-term consequences on graft survival with increased relative risk of graft loss. DGF frequency…
2021 American Transplant Congress
Patient Perspective of the Implementation of Virtual Medicine in a Post-kidney Transplant Clinic
S. Mann¹, M. Kadatz¹, J. Lan¹, O. Johnston¹, C. Luo²
¹Medicine, Division of Nephrology, University of British Columbia, Vancouver, BC, Canada, ²Pharmaceutical Sciences, Vancouver General Hospital, Vancouver, BC, Canada
*Purpose: COVID-19 dramatically altered the model of health care delivery for transplant recipients, necessitating the routine use of virtual medicine. This resulted in consequences for…
2021 American Transplant Congress
Peripheral Blood Hematopoietic Chimerism: A Robust Biomarker for Transplantation Tolerance
D. Tollerud¹, E. Gornstein¹, J. Leventhal², K. V. Ravindra³, S. Ildstad¹
¹Talaris Therapeutics, Louisville, KY, ²Division of Organ Transplantation, Northwestern Medical Group, Chicago, IL, ³Department of Surgery, Duke University Medical Center, Durham, NC
*Purpose: Despite the development of highly effective immunosuppressive medications, organ rejection and the toxicity of the drugs themselves remain significant obstacles to long-term graft and…
2021 American Transplant Congress
Oxalate Nephropathy After Kidney Transplant: Defining Histological Patterns, Contributing Factors and Graft Outcome
N. Jakob¹, A. Chuu¹, J. Ninan¹, E. Lim¹, N. Zhang¹, H. Amer², F. Cosio², H. Wadei³, M. Ryan¹, C. Cortese³, L. Cornell², M. Keddis¹
¹Nephrology, Mayo Clinic, Scottsdale, AZ, ²Nephrology, Mayo Clinic, Rochester, MN, ³Nephrology, Mayo Clinic, Jacksonville, FL
*Purpose: The objective of this study is to evaluate KTx recipients with biopsy proven oxalate nephropathy (ON) to better define risk factors, histologic patterns and…
2021 American Transplant Congress
CT-measured Cortical Volume Ratio is an Alternative to Nuclear Medicine Split Scan Ratio Among Living Kidney Donors
J. Montgomery, C. Brown, A. Zondlak, K. Walsh, J. Kozlowski, A. Pinsky, E. Herriman, J. Sussman, Y. Lu, E. Stein, P. Shankar, R. Sung, K. Woodside
Michigan Medicine, Ann Arbor, MI
*Purpose: The 125I-iothalamate clearance and 99mTc-DTPA split scan nuclear medicine studies are used among living kidney donor candidates to determine mGFR and split-scan ratio (SSR).…
2021 American Transplant Congress
Tru and Sure -A Tale of Two Cities! Can Allosure Predict and Enhance Trugraf Results?
Y. A. Qazi¹, W. Mon¹, S. Qazi², C. Choi¹, M. Smogorzewski¹
¹Keck Medical Center at USC, Los Angeles, CA, ²Keck Medical Center at USC, La Canada Flt, CA
*Purpose: With the introduction of Cell free DNA(cfDNA) technology in transplantation a few years ago, and a more recent addition of genomic testing with TruGraf…